Concepedia

Author

Laurence Leclere

Université Paris Cité

Also Known As

L. Leclere, L. Leclère, Laurence Leclere, Leclere, Laurence

18

Publications

476

Citations

9

H-Index

24

Concepts

All Affiliations

Université Paris CitéInsermAssistance Publique – Hôpitaux de ParisHôpital BeaujonCommissariat à l'Énergie Atomique et aux Énergies Alternatives
LL

About

Laurence Leclere is an author at Université Paris Cité specializing in medicine, molecular diagnostics, and hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

108

2

Social Sciences

1

1

30

3

Biostatistics

1

1

31

4

Epidemiology

1

1

26

5

Hepatology

1

1

21

Laurence Leclere

×

9

Publications

470

Citations

9

H-Index

YearCitations

Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin†

Michelle Martinot‐Peignoux, Christiane Stern, Sarah Maylin,

Hepatology

2009

174

Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a

Rami Moucari, Michelle Martinot-Peignoux, Vincent Mackiewicz,

Antiviral Therapy

2009

74

<i>Gata3</i> hypermethylation and <i>Foxp3</i> hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut‐sensitized mice

Lucie Mondoulet, Vincent Dioszeghy, Florence Busato,

Allergy

2018

69

Comparison of the quantification of KRAS mutations by digital PCR and E-ice-COLD-PCR in circulating-cell-free DNA from metastatic colorectal cancer patients

David Sefrioui, Florence Mauger, Laurence Leclere,

Clinica Chimica Acta

2016

31

Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis

O. Fogel, Andreas Bugge Tinggaard, Maud Fagny,

Arthritis Research & Therapy

2019

31

A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations

Ebba Lohmann, Laurence Leclere, Francesca De Anna,

Parkinsonism & Related Disorders

2008

30

725 QUANTITATIVE HBSAG: A NEW SPECIFIC MARKER FOR THE DIAGNOSIS OF HBSAG INACTIVE CARRIAGE

Michelle Martinot-Peignoux, Rami Moucari, Laurence Leclere,

Journal of Hepatology

2010

26

Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C

Michelle Martinot-Peignoux, Hacène Khiri, Laurence Leclere,

Journal of Clinical Virology

2009

21

Frequency of the &lt;i&gt;LRRK2 &lt;/i&gt;G2019S Mutation in Siblings with Parkinson’s Disease

Suzanne Lesage, Laurence Leclere, Ebba Lohmann,

Neurodegenerative Diseases

2007

14

Page 1